ROLE OF SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERM) IN TREATMENT OF CARCINOMA PROSTATE.

Authors

  • PRATAP SHANKAR Department of Pharmacology & Therapeutics, King George’s Medical University, Lucknow, UP, India-226003
  • D.K. KATIYAR Department of Pharmacology & Therapeutics, King George’s Medical University, Lucknow, UP, India-226003
  • RAKESH KUMAR DIXIT Department of Pharmacology & Therapeutics, King George’s Medical University, Lucknow, UP, India-226003

Keywords:

Prostate Cancer, SERM, Estrogen, Estrogen Receptor

Abstract

The exact mechanism of carcinogenesis is unknown, although it is believed to involve a combination of dietary, environmental, genetic, lifestyle and hormonal causes. Prostate cancer is main problem of men, and it is believed that prostate cancer is the hormonal imbalance of the testosterone but now it has been proved clinically that estrogen hormone imbalance is also involved in the prostate carcinogenesis during the development or later period of the prostate. It required maintaining the balance of the estrogen hormone by some estrogen receptor. In this review we focused on the literature survey on Selective estrogen receptor modulators (SERMs) in prostate carcinogenesis and prevention because SERMs have shown the ability to prevent and treat prostate cancer.

Published

30.09.2013

How to Cite

PRATAP SHANKAR, D.K. KATIYAR, & RAKESH KUMAR DIXIT. (2013). ROLE OF SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERM) IN TREATMENT OF CARCINOMA PROSTATE. International Journal of Pharma and Bio Sciences, 4(3), 201–205. Retrieved from https://ijpbs.net/index.php/journal/article/view/2450

Issue

Section

Review Articles

Categories